May 13, 2026 08:30AM
Apr 7, 2026 08:30AM
Apr 29, 2024 07:04AM
Apr 29, 2024 07:00AM
Apr 19, 2023 08:00AM
Apr 17, 2023 07:00AM
Aug 22, 2022 09:00AM ONCOTELIC REPORTS Q2 2022 COMPARED TO Q2 2021 FINANCIAL RESULTS
May 18, 2022 08:00AM
Apr 18, 2022 07:00AM
Dec 22, 2021 07:15AM
Nov 23, 2021 07:30AM
Nov 16, 2021 08:15AM
Oct 4, 2021 07:00AM
Sep 1, 2021 12:00PM ONCOTELIC TO ACQUIRE LATE-STAGE DRUG CANDIDATE FOR PARKINSON DISEASE, ERECTILE DYSFUNCTION, AND FEMALE SEXUAL DYSFUNCTION.
Aug 24, 2021 07:02AM
Aug 24, 2021 07:00AM
Aug 16, 2021 07:00AM
Jun 15, 2021 09:00AM
May 4, 2021 07:00AM
Apr 20, 2021 12:00PM
Apr 19, 2021 12:00PM ONCOTELIC THERAPEUTICS, INC. ANNOUNCED SYNERGY BETWEEN OT-101 AND IL-2 (PROLEUKIN) AT AACR-2021
Mar 31, 2021 07:00AM
Mar 30, 2021 09:00AM

1,155,348 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All